A Phase 1, Open-Label, Randomized, Cross-Over Study To Estimate The Effects Of Steady-State Cimetidine On The Pharmacokinetics Of A Single Dose Of PD 0332334 In Healthy Subjects.
Phase of Trial: Phase I
Latest Information Update: 10 Dec 2009
At a glance
- Drugs Cimetidine; Imagabalin
- Indications Anxiety disorders; Peptic ulcer
- Focus Pharmacokinetics
- Sponsors Pfizer
- 03 Mar 2009 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
- 25 Feb 2009 Pfizer has decided to discontinue development of this drug for the treatment of generalised anxiety disorder, as reported in a media release.
- 05 Feb 2009 Additional location identified USA as reported by ClinicalTrials.gov, last updated 5 Feb 2008.